The company posted an 11 percent year-over-year decline in OVA1 sales but more than doubled its average revenue per test, to $301 from $143 in Q4 2015.
Protein patterns in patient-derived xenografts sometimes pointed to different alterations than those predicted from somatic mutation and expression data.
The company intends to sell up to $75 million of its common stock for working capital and other purposes.
The agreement combines TTP's Mosquito with AATI's Fragment Analyzer to improve library preparation for next-generation sequencing.
The grant was awarded by the Human Frontier Science Program, which promotes international research collaborations.
The companies will join their respective technologies to offer customers a single solution for next-generation sequencing data interpretation.
The company, which is collaborating with Myeloma Crowd, will use the newly-licensed minicircle DNA technology to develop therapies for multiple myeloma.
The Screen Project is a new initiative started by researchers in the WCH Familial Breast Cancer Research Unit to test men and women for BRCA1 and BRCA2.
The MIT researchers said that the mutational signature could be used to identify people exposed to aflatoxin who are at risk of developing liver cancer.
The proposed cut comes on the heels of a budget proposal that would reduce the NIH's fiscal year 2018 budget by 20 percent.
Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.
Some science companies will be taking part in next month's March for Science, Fortune reports.
In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.
Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.